Evidence map›Paper›PMID 24456626›Full record

ArticleJournal of immunological methods2014

Statistical methods for the assessment of EQAPOL proficiency testing: ELISpot, Luminex, and Flow Cytometry.

Wes Rountree, Nathan Vandergrift, John Bainbridge, Ana M Sanchez, Thomas N Denny

Open access · greenAbstract read
In one paragraph

Article in Journal of immunological methods, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wes RountreeDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA. Electronic address: wes.rountree@dm.duke.edu.
Nathan VandergriftDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA.
John BainbridgeDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA.
Ana M SanchezDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA.
Thomas N DennyDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA.
Duke Medical Center · US

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
NIAID NIH HHS HHSN272201000045CNIAID NIH HHS P30 AI064518
6 · The paper itself

Abstract

In September 2011 Duke University was awarded a contract to develop the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) External Quality Assurance Program Oversight Laboratory (EQAPOL). Through EQAPOL, proficiency testing programs are administered for Interferon-γ (IFN-γ) Enzyme-linked immunosorbent spot (ELISpot), Intracellular Cytokine Staining Flow Cytometry (ICS) and Luminex-based cytokine assays. One of the charges of the EQAPOL program was to apply statistical methods to determine overall site performance. We utilized various statistical methods for each program to find the most appropriate for assessing laboratory performance using the consensus average as the target value. Accuracy ranges were calculated based on Wald-type confidence intervals, exact Poisson confidence intervals, or via simulations. Given the nature of proficiency testing data, which has repeated measures within donor/sample made across several laboratories; the use of mixed effects models with alpha adjustments for multiple comparisons was also explored. Mixed effects models were found to be the most useful method to assess laboratory performance with respect to accuracy to the consensus. Model based approaches to the proficiency testing data in EQAPOL will continue to be utilized. Mixed effects models also provided a means of performing more complex analyses that would address secondary research questions regarding within and between laboratory variability as well as longitudinal analyses.

Indexed as

Models, StatisticalBiomarkersCytokinesData Interpretation, StatisticalEnzyme-Linked Immunospot AssayFlow CytometryGuideline AdherenceHumansInterferon-gamma Release TestsLaboratoriesLaboratory Proficiency TestingMonitoring, ImmunologicObserver VariationPractice Guidelines as TopicPredictive Value of TestsProgram DevelopmentBiomarkersCytokinesELISpotFlow CytometryLuminexMixed effects modelsPoissonProficiency testing

Identifiers

PMID24456626
PMCPMC4104253
OpenAlexW2025029316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.